Tower Research Capital (TRC)’s SCYNEXIS SCYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-226
| Closed | -$1.14K | – | 5508 |
|
|
2025
Q4 | $1.14K | Sell |
226
-103
| -31% | -$561 | ﹤0.01% | 4744 |
|
|
2025
Q3 | $2.02K | Sell |
329
-440
| -57% | -$2.98K | ﹤0.01% | 4694 |
|
|
2025
Q2 | $4.15K | Buy |
+769
| New | +$5.4K | ﹤0.01% | 4371 |
|
|
2025
Q1 | – | Sell |
-445
| Closed | -$4.31K | – | 5714 |
|
|
2024
Q4 | $4.31K | Buy |
445
+30
| +7% | +$311 | ﹤0.01% | 4484 |
|
|
2024
Q3 | $4.95K | Sell |
415
-306
| -42% | -$4.33K | ﹤0.01% | 4361 |
|
|
2024
Q2 | $11.5K | Sell |
721
-1,346
| -65% | -$20.8K | ﹤0.01% | 4076 |
|
|
2024
Q1 | $24.3K | Buy |
2,067
+1,431
| +225% | +$20.2K | ﹤0.01% | 2819 |
|
|
2023
Q4 | $11.3K | Buy |
+636
| New | +$9.33K | ﹤0.01% | 4138 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5882 |
|
|
2023
Q2 | – | Sell |
-1,597
| Closed | -$38K | – | 6329 |
|
|
2023
Q1 | $38K | Buy |
1,597
+1,085
| +212% | +$14.4K | ﹤0.01% | 2757 |
|
|
2022
Q4 | $7K | Sell |
512
-197
| -28% | -$3.48K | ﹤0.01% | 4615 |
|
|
2022
Q3 | $13K | Sell |
709
-1,552
| -69% | -$30.3K | ﹤0.01% | 4287 |
|
|
2022
Q2 | $33K | Buy |
2,261
+2,176
| +2,560% | +$41.9K | ﹤0.01% | 3281 |
|
|
2022
Q1 | $3K | Sell |
85
-178
| -68% | -$6.81K | ﹤0.01% | 5408 |
|
|
2021
Q4 | $13K | Buy |
+263
| New | +$12.9K | ﹤0.01% | 4201 |
|
|
2021
Q3 | – | Sell |
-3,266
| Closed | -$192K | – | 6125 |
|
|
2021
Q2 | $192K | Buy |
3,266
+3,128
| +2,267% | +$197K | 0.01% | 1961 |
|
|
2021
Q1 | $9K | Buy |
+138
| New | +$9.05K | ﹤0.01% | 4432 |
|
|
2020
Q4 | – | Sell |
-164
| Closed | -$6K | – | 5380 |
|
|
2020
Q3 | $6K | Sell |
164
-511
| -76% | -$25K | ﹤0.01% | 4306 |
|
|
2020
Q2 | $41K | Buy |
+675
| New | +$45.8K | ﹤0.01% | 3210 |
|
|
2019
Q3 | – | Sell |
-7
| Closed | -$1K | – | 4472 |
|
|
2019
Q2 | $1K | Sell |
7
-11
| -61% | -$1.27K | ﹤0.01% | 3485 |
|
|
2019
Q1 | $2K | Buy |
+18
| New | +$1.64K | ﹤0.01% | 3451 |
|
|
2018
Q4 | – | Sell |
-2
| Closed | – | – | 4291 |
|
|
2018
Q3 | $0 | Buy |
+2
| New | +$236 | ﹤0.01% | 4188 |
|
|
2018
Q2 | – | Sell |
-18
| Closed | -$2K | – | 4010 |
|
|
2018
Q1 | $2K | Buy |
+18
| New | +$2.48K | ﹤0.01% | 2970 |
|
|
2017
Q3 | – | Sell |
-22
| Closed | -$3K | – | 4099 |
|
|
2017
Q2 | $3K | Buy |
+22
| New | +$3.65K | ﹤0.01% | 2237 |
|
|
2016
Q4 | – | Sell |
-3
| Closed | -$1K | – | 4329 |
|
|
2016
Q3 | $1K | Sell |
3
-7
| -70% | -$1.48K | ﹤0.01% | 3356 |
|
|
2016
Q2 | $2K | Sell |
10
-4
| -29% | -$1.13K | ﹤0.01% | 3958 |
|
|
2016
Q1 | $4K | Buy |
14
+12
| +600% | +$4.54K | ﹤0.01% | 2929 |
|
|
2015
Q4 | $1K | Sell |
2
-1
| -33% | -$527 | ﹤0.01% | 4151 |
|
|
2015
Q3 | $2K | Buy |
3
+2
| +200% | +$1.23K | ﹤0.01% | 3394 |
|
|
2015
Q2 | $1K | Sell |
1
-10
| -91% | -$7.18K | ﹤0.01% | 4060 |
|
|
2015
Q1 | $7K | Buy |
+11
| New | +$9.03K | ﹤0.01% | 3070 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4618 |
|
|
2014
Q3 | – | Sell |
-27
| Closed | -$17K | – | 4833 |
|
|
2014
Q2 | $17K | Buy |
+27
| New | +$18.9K | ﹤0.01% | 1940 |
|
Other funds holding SCYX
SCM
GPP
APM
HCM
KCM
EAM
VCM
DCM
Tower Research Capital (TRC)'s SCYX Position: Q1 2026 in Review
Tower Research Capital (TRC) sold out of SCYNEXIS (SCYX) in Q1 2026, closing a stake of 226 shares — an estimated $1.14K sold.
Tower Research Capital (TRC) first reported a position in SCYX in Q2 2014 and held it in 31 quarters. The position peaked at $192K in Q2 2021. 46 funds tracked by Wall St. Rank hold SCYX as of Q1 2026.
- Tower Research Capital (TRC) reported no remaining SCYNEXIS position as of Q1 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 226 SCYNEXIS shares in Q1 2026, an estimated $1.14K.
- Tower Research Capital (TRC) first reported a position in SCYNEXIS in Q2 2014 and held it in 31 quarters.
- Tower Research Capital (TRC)'s SCYNEXIS position peaked at $192K in Q2 2021.
- 46 funds tracked by Wall St. Rank held SCYNEXIS as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.